Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 122842 | AM251 | 183232-66-8 | 98% |  |
| AM251 is a potent CB1 receptor antagonist (IC50 = 8 nM, Ki = 7.49 nM) that displays 3 | ||||
| 122838 | AZD2858 | 486424-20-8 | 98% |  |
| AZD2858 is a selective GSK-3 inhibitor with an IC50 of 68 nM, inhibits tau phosphoryl | ||||
| 122824 | Adjudin | 252025-52-8 | 98% |  |
| Adjudin is a drug which is under development as a potential non-hormonal male contrac | ||||
| 122822 | AdipoRon | 924416-43-3 | 98% |  |
| AdipoRon is a novel small-molecule AdipoR agonist; binds to both AdipoR1(Kd= 1.8 uM) | ||||
| 122407 | Anamorelin | 249921-19-5 | 98% |  |
| Anamorelin is a synthetic orally active ghrelin receptor agonist which is under devel | ||||
| 122303 | Atorvastatin sodium | 134523-01-6 | 98% |  |
| Atorvastatin has the potential to ameliorate arsenic-induced vascular dysfunction and | ||||
| 122211 | Amrubicin | 110267-81-7 | 98% |  |
| Amrubicin is a novel anthracycline derivative for treatment of bladder carcinoma. | ||||
| 122210 | AG 490 | 134036-52-5 | 98% |  |
| AG-490 is a tyrosine kinase inhibitor of JAK2, EGFR, and Neu that belongs to the fami | ||||
| 121804 | APD597 | 897732-93-3 | 98% |  |
| APD597 is a potent and selective GPR119 agonist, which is potential useful for the tr | ||||
| 121434 | AT-101 | 90141-22-3 | 98% |  |
| AT-101 is the orally bioavailable the R-(-) enantiomer of gossypol with potential ant | ||||
| 120701 | 4-Aminobenzeneboronic Acid Hydrochloride | 80460-73-7 | 98% |  |
| Coming soon! | ||||
| 120409 | Alendronate sodium trihydrate | 121268-17-5 | 98% |  |
| Coming soon! | ||||
| 120408 | Ambroxol hydrochloride | 23828-92-4 | 98% |  |
| Coming soon! | ||||
| 120110 | Actinomycin D | 50-76-0 | 98% |  |
| Actinomycin D is the most significant member of actinomycines, which are a class of p | ||||
| 120104 | Altiratinib | 1345847-93-9 | 98% |  |
| Altiratinib is a novel c-MET/TIE-2/VEGFR inhibitor; effectively reduce tumor burden i | ||||
| 120103 | AGI-5198 | 1355326-35-0 | 98% |  |
| AGI-5198 is a novel R132H-IDH1 inhibitor, identified through a high-throughput screen | ||||
| 120102 | Acotiamide HCl | 773092-05-0 | 98% |  |
| Acotiamide is a drug approved in Japan for the treatment of postprandial fullness, up | ||||
| 120101 | A66 | 1166227-08-2 | 98% |  |
| A66 is a potent and specific p110 inhibitor with IC50 of 32 nM, >100 fold selectiv | ||||
| 112101 | AV-412 | 451492-95-8 | 99.38% |  |
| AV-412 is an EGFR/HER2 inhibitor that binds to and inhibits the epidermal growth fact | ||||
| 111913 | AR-12 | 742112-33-0 | 98% |  |
| AR-12 is an orally available, targeted anti-cancer agent that has been shown in pre-c | ||||
| 110909 | AR 231453 | 733750-99-7 | 98% |  |
| AR231453 is a potent and selective small molecule agonist of GPR119 that enhances glu | ||||
| 110906 | AZD6738 | 1352226-88-0 | 97% |  |
| AZD6738 is an orally available morpholino-pyrimidine-based inhibitor of ataxia telang | ||||
| 110217 | 3-Amino-2,6-dibromopyridine | 39856-57-0 | 98% |  |
| Coming soon! | ||||
| 110214 | 2-Amino-4-(trifluoromethyl)pyridine | 106447-97-6 | 98% | pyridine-cas-106447-97-6.png) |
| Coming soon! | ||||
| 110211 | 1-aminocyclopropanecarboxylic acid | 22059-21-8 | 98% |  |
| Coming soon! | ||||
| 110207 | 3-Amino-1-propanesulfonic acid | 3687-18-1 | 98% |  |
| Coming soon! | ||||
| 102702 | Alda 1 | 349438-38-6 | 98% |  |
| Alda 1 is a cell-permeable benzamide compound that selectively enhances the activity | ||||
| 102619 | ACTB-1003 | 939805-30-8 | 98% |  |
| ACTB-1003 is a potent inhibitor of FGFR1 with IC50 <10 nM in FGFR-1 biochemical as | ||||
| 102613 | ABT-751 | 141430-65-1 | 98% |  |
| ABT-751 is a novel bioavailable tubulin-binding and antimitotic sulfonamide agent wit | ||||
| 102604 | AZD1981 | 802904-66-1 | 98% |  |
| AZD1981 is a potent and selective CRTh2 antagonist; displaces radio-labelled PGD2 fro | ||||